Welcome to our dedicated page for EUDA Health Holdings news (Ticker: EUDAW), a resource for investors and traders seeking the latest updates and insights on EUDA Health Holdings stock.
EUDA Health Holdings Limited reports company developments as a Singapore-based non-invasive healthcare and health technology provider serving markets in Asia, with activities tied to Singapore, Malaysia and China. Its updates include Nasdaq listing-compliance notices, periodic-reporting delays, and disclosures connected to its ordinary shares and listed warrants under EUDA and EUDAW.
Company materials also describe EUDA's operating focus on holistic wellness consumer products and services, digital healthcare ecosystem activities, property management services in Singapore, and selected immunotherapy distribution rights in Malaysia through CK Health Plus Sdn Bhd.
Summary not available.
EUDA Health Holdings Limited (NASDAQ: EUDA, EUDAW), a Singapore-based health technology company, announced it received a delinquency notification from Nasdaq on April 5, 2023, due to its failure to file the Annual Report on Form 10-K for the fiscal year ending December 31, 2022. The company has 60 days to submit a compliance plan. If accepted, it could receive up to 180 days to file the report. Management is working to complete the necessary information but needs additional time for final audits. The delinquency notice does not immediately impact the trading of EUDA's common stock, which remains listed on Nasdaq.